Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Streptococcal infection is prevalent in Guttate Psoriasis while hypocalcaemia is prevelant in Pustular Psoriasis.Our study was to see the prevalence of Hypocalcaemia and Streptoccocal infection in Psoriasis Vulgaris which could help in the prevention and management of the disease

Materials / method: All newly diagnosed untreated, relapsed cases of psoriasis vulgaris were studied for 1 year which fitted into your inclusion and exclusion criteria.
The parameters studied were ASO titre,Throat swab,Serum calcium and Serum albumin & PASI

Results: Total sample size was 55.Male subjects numbered 34 while female subjects were 21.
Few notable results were ,38 patients were above the age of 35 years(69.1%),29 cases were newly diagnosed cases of psoriasis while 26 cases were relapses.The mean PASI score of the patients was17.02 (range 2.1-56.2).Total number of patients found to have streptococcal infection were 12 (21.82%).A total of 28 (50.91%) patients were found to have hypocalcaemia.7 patients(12.72%) had both hypocalcaemia and streptococcal infection while 22 patients(40%) had neither streptococcal infection or hypocalcaemia.

Conclusion: We conclude that both streptococcal infection and hypocalcaemia is prevalent in psoriasis vulgaris and that early treatment of streptococcal sore throat and calcium supplementation may be beneficial for patients with psoriasis vulgaris. We suggest that a controlled trial for assessing the effects of tonsillectomy on patients with severe psoriasis should be considered along with the role of antibiotics in the treatment of psoriasis in patients with a history of sore throat. Patients having psoriasis vulgaris should be investigated for hypocalcaemia and if found to have it should be corrected .

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: Understand the Basic Treatment Concepts for Psoriasis

Introduction: Psoriasis a frequent skin disease. Many treatment options are available for the treatment of psoriasis. But which treatment is the best? What are the current treatment recommendations? For how long should the treatments be given and what recommendations are reasonable?

Materials / method: The European Psoriasis Guidelines are based on a systematic literature search and a structured consensus process (S3 Level).

Results: Topical Treatment is dominated by corticosteroids and Vitamin D and its analogues. Systemic Treatment's mainstay is methotrexate. The Group of biologics consists of anti-TNF Alpha antagonists, anti-Interleukin 17 antibodies, anti - Interleukin 23 and anti Interleukin 12/23 antibodies.

Conclusion: Treatment selection needs to be oriented along patients needs.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): European dermatology forum

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: The new anti-IL-23 biologics introduce new concepts in the treatment of psoriasis and might change our therapeutic strategies. For instance the concept of persistence (or remanence) which might promote a stop and go strategy. Furthermore, a change in the natural history of the disease could also be a hope in the future.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Janssen, Abbvie

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability